Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Glucagon on Renal Blood Flow
NCT06872060Phase 1Not yet recruiting
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Jun 2026
- Primary completion
- Nov 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
Phase 1, randomised, single-blind trial of glucagon in Kidney disease (3 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Blood perfusion of the kidney. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
glucagon
03
Conditions
Kidney disease
Beyond the preview
Go deeper on NCT06872060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06872060.